SCHEMBL20567459

SCHEMBL20567459

NC(=O)Oc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
HTT P42858 1/20 0.59
PLG P00747 1/20 0.55
CA2 P00918 10/20 0.55
CA12 O43570 9/20 0.53
CA9 Q16790 9/20 0.53
CA1 P00915 8/20 0.53
SOS1 Q07889 2/20 0.52
CA7 P43166 5/20 0.50
CA14 Q9ULX7 3/20 0.50
CA3 P07451 1/20 0.50
CA6 P23280 1/20 0.50
CYP2C19 P33261 1/20 0.50
CA5A P35218 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
TSHR P16473 1/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11572730 0.85 ALDH1A1 (0.61) ALDH1A1HTTPLGCA2CA12
SCHEMBL6284986 0.82 KMT2A (0.64) ALDH1A1HTTCA2CA1KMT2A
SCHEMBL27825837 0.82 PTGS2 (0.50) KMT2APOLBMAPTPKMMEN1
SCHEMBL7038709 0.82 POLB (0.46) ALDH1A1HTTPLGCA2CA12
SCHEMBL3536505 0.82 POLB (0.71) ALDH1A1HTTPLGCA2CA12
SCHEMBL28112129 0.79 ALDH1A1 (0.53) ALDH1A1HTTPLGCA2CA12
SCHEMBL1874816 0.79 CA2 (0.59) ALDH1A1HTTCA2CA12CA9
SCHEMBL964748 0.79 CA2 (0.54) ALDH1A1HTTPLGCA2CA12
SCHEMBL27790073 0.78 CA2 (0.53) CA2CA12CA9CA1CA14
SCHEMBL29224978 0.77 MEN1 (0.66) CA2CA12CA9CA1SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180339963-A1 ANTICONVULSANT CARBAMATE DERIVATIVES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2018-11-29 US claimed
CN-113943234-A Preparation method of sulfonylphenylurea herbicide safener 常州大学 2022-01-18 CN disclosed
US-20180339963-A1 ANTICONVULSANT CARBAMATE DERIVATIVES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2018-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180339963-A1 ANTICONVULSANT CARBAMATE DERIVATIVES CNR2, GRIK5, GRIK4 ALDH1A1 1380/4885HTT 1120/4885PLG 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.